Evaluating Temperature Sensitivity of Vesicular Stomatitis Virus-Based Vaccines.
Canada
Ebola virus
Lassa virus
Viral hemorrhagic fever
temperature stability
vaccine stability
vaccines
vesicular stomatitis virus
viruses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
pubmed:
30
5
2019
medline:
24
12
2019
entrez:
30
5
2019
Statut:
ppublish
Résumé
Use of the vesicular stomatitis virus (VSV)-based Ebola virus vaccine during outbreaks and the potential use of a similar VSV-based Lassa virus vaccine has raised questions about the vaccines' stability should the cold chain fail. We demonstrated that current cold chain conditions might tolerate significant variances without affecting efficacy.
Identifiants
pubmed: 31141474
doi: 10.3201/eid2508.190281
pmc: PMC6649338
doi:
Substances chimiques
Ebola Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1563-1566Références
J Infect Dis. 2013 Apr 15;207(8):1316-27
pubmed: 23303805
PLoS Negl Trop Dis. 2015 Apr 17;9(4):e0003736
pubmed: 25884628
Lancet. 2015 Aug 29;386(9996):857-66
pubmed: 26248676
Nature. 2016 Oct 12;538(7624):193-200
pubmed: 27734858
Lancet. 2016 Dec 10;388(10062):2904-2911
pubmed: 27837923
Science. 2018 Mar 16;359(6381):1201-1202
pubmed: 29590055
Drug Des Devel Ther. 2018 Aug 14;12:2519-2527
pubmed: 30147299
NPJ Vaccines. 2019 Feb 8;4:8
pubmed: 30774999
Am J Trop Med Hyg. 1970 Jul;19(4):670-6
pubmed: 4246571
Science. 1974 Jul 19;185(4147):263-5
pubmed: 4833828